申请人:Mitsubishi Pharma Corporation
公开号:EP1346724A1
公开(公告)日:2003-09-24
Excellent remedies for hepatitis C which contain as the active ingredients a 3'-deoxy-3'-fluorouridine derivatives and a 1-(3'-deoxy-fluoro-β-L-ribofuranosyl)uracil derivative and show little side effects.
治疗丙型肝炎的良药,其有效成分为 3'-deoxy-3'-fluorouridine 衍生物和 1-(3'-deoxy-fluoro-β-L-ribofuranosyl)uracil 衍生物,副作用小。